E

Exprivia SpA
MIL:XPR

Watchlist Manager
Exprivia SpA
MIL:XPR
Watchlist
Price: 1.52 EUR -12.14% Market Closed
Market Cap: 78.9m EUR

Intrinsic Value

The intrinsic value of one XPR stock under the Base Case scenario is 3.46 EUR. Compared to the current market price of 1.52 EUR, Exprivia SpA is Undervalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XPR Intrinsic Value
3.46 EUR
Undervaluation 56%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
Exprivia SpA

XPR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for XPR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Exprivia SpA
MIL:XPR
IT
Technology
Market Cap
78.9m EUR
IPO
Nov 18, 1999
IT
Technology
Market Cap
78.9m EUR
IPO
Nov 18, 1999
Price
€false
EPS
€false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XPR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Exprivia SpA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Exprivia SpA

Current Assets 126m
Cash & Short-Term Investments 24.1m
Receivables 69.4m
Other Current Assets 32.5m
Non-Current Assets 97.4m
Long-Term Investments 1.2m
PP&E 17.4m
Intangibles 76.4m
Other Non-Current Assets 2.3m
Efficiency

Free Cash Flow Analysis
Exprivia SpA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Exprivia SpA

Revenue
195m EUR
Cost of Revenue
-10.7m EUR
Gross Profit
184.3m EUR
Operating Expenses
-162.9m EUR
Operating Income
21.4m EUR
Other Expenses
-8.2m EUR
Net Income
13.1m EUR
Fundamental Scores

XPR Profitability Score
Profitability Due Diligence

Exprivia SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
Positive Free Cash Flow
Positive 3-Years Revenue Growth
50/100
Profitability
Score

Exprivia SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

XPR Solvency Score
Solvency Due Diligence

Exprivia SpA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Exprivia SpA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XPR Price Targets Summary
Exprivia SpA

There are no price targets for XPR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for XPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one XPR stock?

The intrinsic value of one XPR stock under the Base Case scenario is 3.46 EUR.

Is XPR stock undervalued or overvalued?

Compared to the current market price of 1.52 EUR, Exprivia SpA is Undervalued by 56%.

Back to Top